The updated indiana university experience with nerve sparing rplnd: effective organ preserving therapy

John P. Donohue, Richard Foster, Richard Bihrle, Randall G. Rowland, Gregory R. Wahle

Research output: Contribution to journalArticle

Abstract

Organ sparing surgical therapy of testis cancer involves preservation of sympathetic efferent nerves to maintain emission and ejaculation. We reviewed the updated experience with modified nerve sparing RPLND in patients with clinical stage I nonseminoma. From 1984 to 1996, 489 clinical stage I patients were subjected to modified nerve sparing RPLND. Follow up data was developed through a computerized database and correspondence. Eighty four (37%) of 227 patients with left sided primaries were found to be pathologic stage II. Seventy nine (30%) of 262 patients with right sided primaries were found to be pathologic stage II. Overall, 163 of 489 (33% ) were pathologic stage II, Of 227 left modified nerve sparing patients, ejaculation status is currently unknown in 33 (14%). Of 262 right modified nerve sparing patients, ejaculatory status is unknown in 38 (14%). Of the 419 patients with available follow up, all report emission and antegrade ejaculation. In this cohort of patients, performance of nerve sparing had no adverse effect on ultimate outcome compared to historical controls. Modified nerve sparing RPLND in clinical stage I nonseminoma effectively and reliably preserves emission and ejaculation. Organ sparing therapy in the surgical treatment of testicular cancer has proven reliable in the long term.

Original languageEnglish
Pages (from-to)289
Number of pages1
JournalBritish Journal of Urology
Volume80
Issue numberSUPPL. 2
StatePublished - 1997

Fingerprint

Ejaculation
Testicular Neoplasms
Therapeutics
Patient Rights
Databases

ASJC Scopus subject areas

  • Urology

Cite this

The updated indiana university experience with nerve sparing rplnd : effective organ preserving therapy. / Donohue, John P.; Foster, Richard; Bihrle, Richard; Rowland, Randall G.; Wahle, Gregory R.

In: British Journal of Urology, Vol. 80, No. SUPPL. 2, 1997, p. 289.

Research output: Contribution to journalArticle

@article{0fde9360b9e94ba28e78edc3b3b64764,
title = "The updated indiana university experience with nerve sparing rplnd: effective organ preserving therapy",
abstract = "Organ sparing surgical therapy of testis cancer involves preservation of sympathetic efferent nerves to maintain emission and ejaculation. We reviewed the updated experience with modified nerve sparing RPLND in patients with clinical stage I nonseminoma. From 1984 to 1996, 489 clinical stage I patients were subjected to modified nerve sparing RPLND. Follow up data was developed through a computerized database and correspondence. Eighty four (37{\%}) of 227 patients with left sided primaries were found to be pathologic stage II. Seventy nine (30{\%}) of 262 patients with right sided primaries were found to be pathologic stage II. Overall, 163 of 489 (33{\%} ) were pathologic stage II, Of 227 left modified nerve sparing patients, ejaculation status is currently unknown in 33 (14{\%}). Of 262 right modified nerve sparing patients, ejaculatory status is unknown in 38 (14{\%}). Of the 419 patients with available follow up, all report emission and antegrade ejaculation. In this cohort of patients, performance of nerve sparing had no adverse effect on ultimate outcome compared to historical controls. Modified nerve sparing RPLND in clinical stage I nonseminoma effectively and reliably preserves emission and ejaculation. Organ sparing therapy in the surgical treatment of testicular cancer has proven reliable in the long term.",
author = "Donohue, {John P.} and Richard Foster and Richard Bihrle and Rowland, {Randall G.} and Wahle, {Gregory R.}",
year = "1997",
language = "English",
volume = "80",
pages = "289",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - The updated indiana university experience with nerve sparing rplnd

T2 - effective organ preserving therapy

AU - Donohue, John P.

AU - Foster, Richard

AU - Bihrle, Richard

AU - Rowland, Randall G.

AU - Wahle, Gregory R.

PY - 1997

Y1 - 1997

N2 - Organ sparing surgical therapy of testis cancer involves preservation of sympathetic efferent nerves to maintain emission and ejaculation. We reviewed the updated experience with modified nerve sparing RPLND in patients with clinical stage I nonseminoma. From 1984 to 1996, 489 clinical stage I patients were subjected to modified nerve sparing RPLND. Follow up data was developed through a computerized database and correspondence. Eighty four (37%) of 227 patients with left sided primaries were found to be pathologic stage II. Seventy nine (30%) of 262 patients with right sided primaries were found to be pathologic stage II. Overall, 163 of 489 (33% ) were pathologic stage II, Of 227 left modified nerve sparing patients, ejaculation status is currently unknown in 33 (14%). Of 262 right modified nerve sparing patients, ejaculatory status is unknown in 38 (14%). Of the 419 patients with available follow up, all report emission and antegrade ejaculation. In this cohort of patients, performance of nerve sparing had no adverse effect on ultimate outcome compared to historical controls. Modified nerve sparing RPLND in clinical stage I nonseminoma effectively and reliably preserves emission and ejaculation. Organ sparing therapy in the surgical treatment of testicular cancer has proven reliable in the long term.

AB - Organ sparing surgical therapy of testis cancer involves preservation of sympathetic efferent nerves to maintain emission and ejaculation. We reviewed the updated experience with modified nerve sparing RPLND in patients with clinical stage I nonseminoma. From 1984 to 1996, 489 clinical stage I patients were subjected to modified nerve sparing RPLND. Follow up data was developed through a computerized database and correspondence. Eighty four (37%) of 227 patients with left sided primaries were found to be pathologic stage II. Seventy nine (30%) of 262 patients with right sided primaries were found to be pathologic stage II. Overall, 163 of 489 (33% ) were pathologic stage II, Of 227 left modified nerve sparing patients, ejaculation status is currently unknown in 33 (14%). Of 262 right modified nerve sparing patients, ejaculatory status is unknown in 38 (14%). Of the 419 patients with available follow up, all report emission and antegrade ejaculation. In this cohort of patients, performance of nerve sparing had no adverse effect on ultimate outcome compared to historical controls. Modified nerve sparing RPLND in clinical stage I nonseminoma effectively and reliably preserves emission and ejaculation. Organ sparing therapy in the surgical treatment of testicular cancer has proven reliable in the long term.

UR - http://www.scopus.com/inward/record.url?scp=33749294532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749294532&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749294532

VL - 80

SP - 289

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - SUPPL. 2

ER -